Your browser doesn't support javascript.
loading
Assessment and management of asthma exacerbations in an emergency department unit.
Douros, Konstantinos; Moriki, Dafni; Sardeli, Olympia; Boutopoulou, Barbara; Galani, Angeliki; Papaevangelou, Vasiliki; Priftis, Kostas N.
Afiliación
  • Douros K; 3rd Department of Pediatrics, "Attikon" University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece; costasdouros@gmail.com.
  • Moriki D; 3rd Department of Pediatrics, "Attikon" University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Sardeli O; 3rd Department of Pediatrics, "Attikon" University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Boutopoulou B; 3rd Department of Pediatrics, "Attikon" University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Galani A; Pediatric Center of Athens, Marousi, Athens, Greece.
  • Papaevangelou V; 3rd Department of Pediatrics, "Attikon" University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Priftis KN; 3rd Department of Pediatrics, "Attikon" University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Allergol Immunopathol (Madr) ; 51(1): 74-76, 2023.
Article en En | MEDLINE | ID: mdl-36617824
ABSTRACT

BACKGROUND:

The Pediatric Respiratory Assessment Measure (PRAM) score is a useful tool for the assessment of asthma exacerbations in children. This study aimed to estimate the risk of hospitalization in children, assessed with the PRAM score and having mild-moderate asthma exacerbation, who were treated with salbutamol delivered via a metered-dose inhaler and spacer (MDI/S).

METHODS:

The study population consisted of children aged 3-16 years with mild-moderate asthma exacerbations. All children received 1mg/kg prednisolone p.o. (max 40 mg) and 4-6 puffs of salbutamol via MDI/S.

RESULTS:

Fifty patients participated in the study. Admission was associated positively with the initial PRAM score (OR 18.91, CI 2.42-123.12, P = 0.005) and negatively with the improvement in PRAM score (OR 0.52, CI 0.01-0.78, P = 0.032).

CONCLUSION:

PRAM is a reliable tool that can be used effectively to estimate the asthma exacerbation severity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Broncodilatadores Tipo de estudio: Diagnostic_studies Límite: Child / Humans Idioma: En Revista: Allergol Immunopathol (Madr) Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Broncodilatadores Tipo de estudio: Diagnostic_studies Límite: Child / Humans Idioma: En Revista: Allergol Immunopathol (Madr) Año: 2023 Tipo del documento: Article